| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 523.10M | 307.75M | 173.98M | 159.24M | 142.41M | 93.58M |
| Gross Profit | 72.73M | 48.93M | 30.18M | 39.19M | 34.76M | 24.90M |
| EBITDA | 39.46M | 17.51M | 11.29M | 5.17M | 12.38M | 23.73M |
| Net Income | 26.25M | 11.17M | 2.55M | -6.68M | 19.56M | 16.25M |
Balance Sheet | ||||||
| Total Assets | 448.53M | 422.21M | 377.37M | 350.58M | 365.22M | 330.70M |
| Cash, Cash Equivalents and Short-Term Investments | 35.49M | 32.38M | 37.61M | 30.86M | 31.09M | 32.26M |
| Total Debt | 59.09M | 69.17M | 78.17M | 49.10M | 42.61M | 20.50M |
| Total Liabilities | 163.63M | 161.70M | 125.36M | 94.83M | 81.69M | 80.09M |
| Stockholders Equity | 255.65M | 234.77M | 228.43M | 230.85M | 253.06M | 228.00M |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -2.56M | -27.17M | -10.38M | -28.46M | -9.23M |
| Operating Cash Flow | 0.00 | 11.29M | -16.06M | 5.63M | -10.91M | 4.03M |
| Investing Cash Flow | 0.00 | -9.27M | -7.14M | -15.64M | -9.84M | -10.87M |
| Financing Cash Flow | 0.00 | -7.07M | 30.23M | 10.38M | 19.36M | 249.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$754.17M | 10.63 | 9.75% | 7.52% | -24.96% | -26.43% | |
68 Neutral | HK$643.72M | 28.90 | 1.87% | 9.43% | -1.99% | -81.52% | |
62 Neutral | HK$1.48B | 5.94 | 12.24% | ― | 153.95% | 551.46% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
49 Neutral | HK$727.87M | -3.86 | -40.38% | ― | -43.46% | -96.48% | |
46 Neutral | HK$382.53M | -27.64 | -1.16% | 7.50% | 59.60% | -351.02% | |
44 Neutral | HK$236.50M | -3.51 | -13.08% | ― | -19.28% | -42.27% |
Chia Tai Enterprises International Limited has issued an inside information announcement indicating it expects a substantial rise in consolidated profit attributable to shareholders to about US$32 million for the year ended 31 December 2025, up from US$11.2 million a year earlier. The improvement is mainly driven by significantly higher revenue stemming from the successful execution of its strategy to boost sales to key customers, even as demand for animal health products weakened from the third quarter of 2025 due to a slowdown in China’s animal farming sector; quarterly revenue in the final three months of 2025 is expected to remain broadly in line with the preceding quarter, and the company plans to publish its full 2025 annual results around the end of February 2026, while cautioning shareholders and potential investors about trading in its shares ahead of the final figures.
The most recent analyst rating on (HK:3839) stock is a Hold with a HK$7.50 price target. To see the full list of analyst forecasts on Chia Tai Enterprises International stock, see the HK:3839 Stock Forecast page.
Chia Tai Enterprises International Limited has updated the terms of reference for its Audit Committee, originally established by the board of directors in 2014. The Committee, which consists solely of non-executive directors, is responsible for overseeing the company’s financial reporting and audit processes. The recent amendments to the terms of reference, effective from November 2025, aim to enhance the governance and operational efficiency of the Committee, ensuring compliance with relevant regulations and improving stakeholder confidence in the company’s financial oversight.
The most recent analyst rating on (HK:3839) stock is a Hold with a HK$9.00 price target. To see the full list of analyst forecasts on Chia Tai Enterprises International stock, see the HK:3839 Stock Forecast page.
Chia Tai Enterprises International Limited has updated the terms of reference for its Remuneration Committee, which was initially established by the board of directors in 2014. The committee is responsible for developing a transparent remuneration policy for directors and senior management, ensuring alignment with corporate goals and industry standards. The updated terms emphasize the committee’s authority to recommend remuneration structures and recruitment guidelines for senior management, aiming to enhance governance and operational efficiency.
The most recent analyst rating on (HK:3839) stock is a Hold with a HK$9.00 price target. To see the full list of analyst forecasts on Chia Tai Enterprises International stock, see the HK:3839 Stock Forecast page.
Chia Tai Enterprises International Limited has updated the terms of reference for its Nomination Committee, which was initially established in 2014. The committee’s responsibilities include formulating and implementing policies related to nominations, board diversity, and workforce diversity, as well as reviewing the board’s structure and composition to align with the company’s strategic needs.
The most recent analyst rating on (HK:3839) stock is a Hold with a HK$9.00 price target. To see the full list of analyst forecasts on Chia Tai Enterprises International stock, see the HK:3839 Stock Forecast page.
Chia Tai Enterprises International Limited announced its unaudited consolidated results for the nine months ended September 30, 2025, reporting a significant increase in revenue and profit compared to the previous year. The company’s profit before tax rose to US$33.855 million from US$7.399 million, indicating strong operational performance and improved market positioning, benefiting both shareholders and non-controlling interests.
The most recent analyst rating on (HK:3839) stock is a Hold with a HK$9.00 price target. To see the full list of analyst forecasts on Chia Tai Enterprises International stock, see the HK:3839 Stock Forecast page.